Date of Birth
November 25th, 1953
Tomas Berl Professor of Medicine, University of Colorado Denver, Professor of Physiology and Biophysics, and Chief, Division of Renal Diseases and Hypertension , University of Colorado Denver
Undergraduate at University of Wisconsin, Madison, Wisconsin; BS in Anthropology (with honors) 1975; Medical School at University of Minnesota, Minneapolis, Minnesota, 1979
Frequent ASN abstract reviewer or Chair, ASN Awards Committee 1995-1998; ASN Career Enhancement Award Committee 1998-2000; ASN Carl Gottschalk Research Scholarship Committee 1998-2000; John Peters Award Committee, American Society of Nephrology 2006-2009; ASN Council Election Committee 2007-2008; ASN Board Review in San Francisco (multiple years).
Societies and Honors
Phi Beta Kappa (Junior year, 1974 Univ of WI), Alpha Omega Alpha (Junior year, 1978 Univ of MN), Inaugural Priscilla Kincaid-Smith Visiting Professor, 1993; Young Investigator Award, American Society of Nephrology and American Heart Association, Orlando, Florida, 1994; American Society of Clinical Investigation, 1995; British Medical Association Book Competition in Medicine, Highly Commended award for Comprehensive Clinical Nephrology, First edition; Brenner Lecture, American Society of Nephrology meeting, San Diego, 2003; Elected to Thomas Reuters ISIhighlycited.com as one of the 250 most cited researchers in the field of Clinical Medicine for period from 1992 to 2012 (>20,000 citations); Jaime Herrera Lecture, Mexican Society of Nephrology, 2006; Sir Stanley Davidson Lecturer, Royal College of Physicians of Scotland, Edinburgh Oct 2006; Donald Seldin Lecture, AHA annual meeting, Orlando FL Nov 2007; Hugh DeWardener Lecture, British Society, Glasgow May 2008; Best Doctors in America 1996 to 2006 and 2009 to 2012; American Clinical Climatologic Society (Theodore Woodward Lectureship); International Society of Nephrology; Councilor, Executive Committee Member, and Scientific Director of ISN 2011 in Vancouver CA; Editor, Comprehensive Clinical Nephrology (editions 1 through 4);Who’sWho in America (Marquis); Who’s Who in America (Madison); University of Colorado Denver Medical Campus New Inventor of the Year 2011
Reviewing Editor, Journal of the American Society of Nephrology 1992-2001, Member of Editorial Board, Journal of the American Society of Nephrology 2001-2002; Consulting Editor, Kidney International 1996-1999; Consulting Editor, Nephrology 1995-1997; Associate Editor, American Journal of Kidney Disease 1996-2001; Member of Editorial Board, American Journal of Physiology, Renal Physiology 2000-2004; Member of Editorial Board, Hypertension, 2003 – 2010; Member of Editorial Board, Kidney International 2004-2006; Member of Editorial Board, American Journal of Nephrology, 2003-present; Advisory Board, “In Translation” Feature for American Journal of Kidney Diseases, 2007-2014; Editorial Board, Nephron Experimental Nephrology, 2007-2010; Internal and Emergency Medicine, Advisory Board (2007-); Editorial Board, Internet Journal of Nephrology (2007-); Editorial Board, Am J Physiol Renal Physiol (2008-); Editorial Board, Nature Clinical Practice Nephrology (2009-)
I have performed both basic, translational and clinical research. Major interests have included the pathogenesis of glomerulonephritis and nephrotic syndrome, and the underlying mechanisms driving diabetic and nondiabetic renal disease. I have also been interested in mechanisms underlying acute renal failure. I have also a longstanding interest in the role of subtle renal injury in causing hypertension, and specifically on the role of the microvasculature and inflammatory cells. Most of my current work is focused on the role of fructose and uric acid in the pathogenesis of acute and chronic renal disease, and also in the pathogenesis of metabolic syndrome and diabetes. I also have some research interests in the epidemics of chronic kidney disease occurring in Nicaragua and Sri Lanka, and also in the renal disease that occurs at high altitude.